| タイトル |
-
en
Neurofeedback Control of the Human GABAergic System Using Non-invasive Brain Stimulation
|
| 作成者 |
|
| アクセス権 |
open access |
| 権利情報 |
-
en
© 2018. This manuscript version is made available under the CC-BY-NC-ND 4.0 license https://creativecommons.org/licenses/by-nc-nd/4.0/
- https://creativecommons.org/licenses/by-nc-nd/4.0/
-
en
Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International
|
| 主題 |
-
Other
en
learning
-
Other
en
neurofeedback
-
Other
en
GABAergic neuron
-
Other
en
intracortical inhibition
-
Other
en
transcranial magnetic stimulation
-
NDC
490
|
| 内容注記 |
-
Abstract
en
Neurofeedback has been a powerful method for self-regulating brain activities to elicit potential ability of human mind. GABA is a major inhibitory neurotransmitter in the central nervous system. Transcranial magnetic stimulation (TMS) is a tool that can evaluate the GABAergic system within the primary motor cortex (M1) using paired-pulse stimuli, short intracortical inhibition (SICI). Herein we investigated whether neurofeedback learning using SICI enabled us to control the GABAergic system within the M1 area. Forty-five healthy subjects were randomly divided into two groups: those receiving SICI neurofeedback learning or those receiving no neurofeedback (control) learning. During both learning periods, subjects made attempts to change the size of a circle, which was altered according to the degree of SICI in the SICI neurofeedback learning group, and which was altered independent of the degree of SICI in the control learning group. Results demonstrated that the SICI neurofeedback learning group showed a significant enhancement in SICI. Moreover, this group showed a significant reduction in choice reaction time compared to the control group. Our findings indicate that humans can intrinsically control the intracortical GABAergic system within M1 and can thus improve motor behaviors by SICI neurofeedback learning. SICI neurofeedback learning is a novel and promising approach to control our neural system and potentially represents a new therapy for patients with abnormal motor symptoms caused by CNS disorders.
|
| 出版者 |
en
Elsevier
|
| 日付 |
|
| 言語 |
|
| 資源タイプ |
journal article |
| 出版タイプ |
AM |
| 資源識別子 |
HDL
http://hdl.handle.net/2115/74506
|
| 関連 |
-
isVersionOf
DOI
https://doi.org/10.1016/j.neuroscience.2018.03.051
-
PMID
29649513
|
| 収録誌情報 |
-
-
en
Neuroscience
-
巻380
開始ページ38
終了ページ48
|
| ファイル |
|
| コンテンツ更新日時 |
2023-07-26 |
